HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ryutaro Fukui Selected Research
Ryutaro Fukui Research Topics
Disease
4
Inflammation (Inflammations)
10/2021 - 07/2011
3
Autoimmune Diseases (Autoimmune Disease)
01/2021 - 08/2012
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 01/2018
1
Bites and Stings (Sting)
10/2021
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
10/2021
1
Disease Progression
01/2021
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019
1
Infections
10/2018
1
Hepatitis
01/2018
1
Massive Hepatic Necrosis
01/2017
1
Cytokine Release Syndrome
01/2017
1
Colitis
06/2013
1
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2011
1
Sepsis (Septicemia)
11/2007
Drug/Important Bio-Agent (IBA)
3
DNA (Deoxyribonucleic Acid)
IBA
10/2021 - 01/2013
3
Nucleic Acids
IBA
10/2021 - 08/2012
2
Interferons
IBA
10/2021 - 06/2013
2
Toll-Like Receptor 7
IBA
01/2021 - 07/2011
2
Double-Stranded RNA (RNA, Double Stranded)
IBA
10/2018 - 06/2013
2
Toll-Like Receptor 9
IBA
01/2017 - 01/2013
2
Ligands
IBA
01/2017 - 01/2016
1
RNA (Ribonucleic Acid)
IBA
10/2021
1
immune RNA (I-RNA)
IBA
01/2021
1
Autoantibodies
IBA
01/2021
1
Azacitidine (5 Azacytidine)
FDA Link
01/2019
1
Phosphotransferases (Kinase)
IBA
10/2018
1
Chemokines
IBA
10/2018
1
Mechanistic Target of Rapamycin Complex 2
IBA
10/2018
1
Galactosamine
IBA
01/2017
1
nas
IBA
08/2012
1
Proteasome Inhibitors
IBA
01/2011
1
Lipopolysaccharides
IBA
11/2007
Therapy/Procedure
1
Therapeutics
01/2019